DNA immunization induces protective immunity against B-cell lymphoma.
about
Screening of protective antigens of Japanese encephalitis virus by DNA immunization: a comparative study with conventional viral vaccinesConstruction of miniantibodies for the in vivo study of human autoimmune diseases in animal modelsWhy do B cell lymphoma fail to elicit clinically sufficient T cell immune responses?Molecular analysis of immunoglobulin genes in multiple myeloma.B-cell malignancies as a model for cancer vaccines: from prototype protein to next generation genetic chemokine fusions.Deviation of the allergic IgE to an IgG response by gene immunotherapy.Genetic immunization with CDR3-based fusion vaccine confers protection and long-term tumor-free survival in a mouse model of lymphomaGranulocyte-macrophage colony-stimulating factor priming plus papillomavirus E6 DNA vaccination: effects on papilloma formation and regression in the cottontail rabbit papillomavirus--rabbit model.Enantiospecific adjuvant activity of cationic lipid DOTAP in cancer vaccine.Immunostimulatory DNA sequences and cancer therapy.Immunotherapy: on the edge between experimental and clinical oncology.Tumour immunotherapy: new tools, new treatment modalities and new T-cell antigens.Vaccine therapy of B cell malignancies: different strategies for a novel approach.Vaccines in oncology: background and clinical potential.Gene therapy for paediatric leukaemia.Recent advances in dendritic cell vaccines for cancer treatment.Immunomodulatory gene therapy for haematological malignancies.Immunotherapy in multiple myeloma: current strategies and future prospects.Comparison of adenoviruses as oncolytics and cancer vaccines in an immunocompetent B cell lymphoma modelTargeting dendritic cells for priming cellular immune responses.Idiotype vaccines in the treatment of B-cell non-Hodgkin's lymphoma.Cytotoxic T cells generated against heteroclitic peptides kill primary tumor cells independent of the binding affinity of the native tumor antigen peptide.DNA vaccines to attack cancerDNA vaccines for poultry: the jump from theory to practice.Current advances, problems and prospects for vaccine-based immunotherapy in follicular non-Hodgkin's lymphoma.A vaccine directed to B cells and produced by cell-free protein synthesis generates potent antilymphoma immunityT cell targeted immunotherapy for autoimmune disease.Idiotypes as immunogens: facing the challenge of inducing strong therapeutic immune responses against the variable region of immunoglobulinsTrial watch: Peptide vaccines in cancer therapyTumor-associated embryonic antigen-expressing vaccines that target CCR6 elicit potent CD8+ T cell-mediated protective and therapeutic antitumor immunityDNA vaccines for cancer therapy.Anti-idiotypic DNA vaccines for lymphoma immunotherapy require the presence of both variable region genes for tumor protection.Melanoma vaccines: prospects for the treatment of melanoma.Targeted DNA vaccines for enhanced induction of idiotype-specific B and T cells.Colorectal cancer vaccines.Immunotherapy for B-cell lymphoma: current status and prospective advancesMolecular analysis of human immunoglobulin heavy chain variable genes (IgVH) in normal and malignant B cellsVaccination with DNA encoding an immunodominant myelin basic protein peptide targeted to Fc of immunoglobulin G suppresses experimental autoimmune encephalomyelitis.Gene expression and immune response kinetics using electroporation-mediated DNA delivery to muscle.Induction of tumor immunity by autologous B lymphoma cells expressing a genetically engineered idiotype.
P2860
Q27469754-BE3BA53A-C5D8-4A96-A0C0-1FAF79CE5065Q33293219-FA892D5C-F18D-4230-ADF6-A1B2EA12492EQ33536297-62ED9F42-41BC-4A7D-8FA1-6DCDC66635C9Q33604355-0130D542-F594-487B-8D32-FB29C59583ABQ33776141-D78429C7-019D-4BC0-8B72-74550EE66E01Q33805880-1BA56538-831A-4B18-9594-EEA24B182EFEQ33814247-D6FFA5B8-F155-4710-9576-DB4266DFB08DQ33874465-04D58B88-5646-4408-B097-133882369027Q33912706-7D067051-BFCE-46F3-BC6D-74AF8A6B70E8Q34005429-810CF4D3-C6DB-4932-BDCF-18A005181D72Q34172095-838D46A9-A64E-476F-ACC6-161512126ABAQ34265381-3ACBE684-79DA-4367-B331-3D96CE97B365Q34430359-F6EBF8BF-A83C-44B5-AEF5-182037CE8388Q34439914-2399B0C2-F31D-4991-B154-9225FF7C9E0EQ34451905-72F13613-CCA4-405B-A7EC-51E3183F4051Q34480504-ED79948A-89A9-4625-A954-63A71B0C4193Q34579664-3EED8188-C788-4F05-93C2-6D9BC841EE23Q35194182-EFEBAFA2-E80E-42D5-A1E5-BAFCC89C82EEQ35226109-890254F2-F09C-484D-B247-1F2C8C90C1E1Q35549421-3AFCF9B4-62F5-46E2-BB7B-1D01BBD06B66Q35740264-0327867F-F96B-44F8-8184-C607C1724E3DQ35848862-B6E6629C-CEAA-45AD-A92F-F1609C3BB5E0Q35855143-FF3471F9-7594-4939-96C7-E980DE1F19FDQ36066247-19F31865-0528-4BA0-AA80-1B04406F5C4EQ36194606-9BCEB15F-59A3-41F7-8507-7AB35E20C7E7Q36221727-B2543C51-6CD2-43BA-83B1-9260F1BD27BAQ36359571-900BF6E2-39C3-4F70-8267-C0810CD12202Q36386109-F2C86E3B-4F0A-47A2-A95A-B6B4AB41B597Q36476100-E47B809C-F0E2-48BB-90E4-988A1B7D9B0BQ36627887-C44073F6-19A4-42D6-8E77-469018B55D6EQ40732047-73DD79AD-309A-4423-8029-25FD9A4909A1Q40878837-2A6855F3-1140-4A6B-AA34-C76E5AEC632FQ40900776-AD72947B-5028-4BF0-BA63-96ADA9CA6C6AQ41648531-8A2721C0-FD47-4776-8638-6084CFD29100Q41720736-C99F7587-25AE-4E82-BE87-B3029DBFC5A4Q41831989-044724AC-F10B-4EFB-91A4-6580C51D90B8Q41912026-64C1C828-CF60-4835-9DBA-BDAAE08BB5B5Q42063824-463AB73B-18E9-4720-B200-A1C77AAD821BQ45130728-59B9C717-6E76-4D4F-9518-E62D0F637E60Q45862530-056B2436-B5BB-4353-B4F4-A8E4155F6DD0
P2860
DNA immunization induces protective immunity against B-cell lymphoma.
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年学术文章
@wuu
1996年学术文章
@zh-cn
1996年学术文章
@zh-hans
1996年学术文章
@zh-my
1996年学术文章
@zh-sg
1996年學術文章
@yue
1996年學術文章
@zh
1996年學術文章
@zh-hant
name
DNA immunization induces protective immunity against B-cell lymphoma.
@en
DNA immunization induces protective immunity against B-cell lymphoma.
@nl
type
label
DNA immunization induces protective immunity against B-cell lymphoma.
@en
DNA immunization induces protective immunity against B-cell lymphoma.
@nl
prefLabel
DNA immunization induces protective immunity against B-cell lymphoma.
@en
DNA immunization induces protective immunity against B-cell lymphoma.
@nl
P2093
P2860
P356
P1433
P1476
DNA immunization induces protective immunity against B-cell lymphoma.
@en
P2093
P2860
P2888
P304
P356
10.1038/NM0996-1038
P407
P577
1996-09-01T00:00:00Z
P5875
P6179
1018875546